HF
ENTX icon

HRT Financial’s Entera Bio ENTX Stock Holding History

HRT Financial’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17K Buy
+15,492
New +$21.7K ﹤0.01% 3586
2023
Q3 		– Sell
-26,414
Closed -$22K – 2574
2023
Q2 		$22K Buy
+26,414
New +$22.6K ﹤0.01% 2087
2023
Q1 		– Sell
-15,236
Closed -$11K – 2661
2022
Q4 		$11K Buy
+15,236
New +$11K ﹤0.01% 2215

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

HRT Financial's ENTX Position: Q1 2026 in Review

HRT Financial opened a new position in Entera Bio (ENTX) in Q1 2026: 15,492 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #3586 among its holdings. This is a return to the name: HRT Financial previously reported a position in ENTX as recently as Q2 2023.

HRT Financial first reported a position in ENTX in Q4 2022 and has held it in 3 quarters since. The position peaked at $22K in Q2 2023. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • HRT Financial held 15,492 shares of Entera Bio worth $17K as of Q1 2026.
  • Entera Bio was a new HRT Financial position in Q1 2026.
  • Entera Bio made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3586 holding.
  • HRT Financial first reported a position in Entera Bio in Q4 2022 and has held it in 3 quarters since.
  • HRT Financial's Entera Bio position peaked at $22K in Q2 2023.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.